Emerging Biotechnology Player Despite its small size and ongoing legal challenges, Arrayit Corporation is positioned within the competitive biotechnology research industry, focusing on proprietary life science technologies for disease prevention, treatment, and diagnostics, presenting potential opportunities to supply specialized research tools or licensing partnerships.

Innovative Diagnostics Development Arrayit has demonstrated capabilities in allergy and COVID-19 testing through automated portals and product bundling strategies, indicating a demand for advanced diagnostic platforms and reagents that could be expanded or integrated with other healthcare solutions.

Regulatory and Compliance Risks The company's history of securities fraud and healthcare conspiracy charges suggests a need for robust regulatory compliance and transparent communication, representing opportunities to offer risk mitigation solutions or compliance consulting services to prevent future legal issues.

Potential for Niche Market Expansion With a small revenue base and a focus on personalized medicine, there is potential to leverage emerging trends in genomics and precision medicine by providing innovative lab reagents, testing kits, or software solutions tailored to boutique and niche biotech firms.

Technology and Software Opportunities Arrayit's use of web-based testing portals and modern tech stacks presents opportunities to supply tailored software solutions, automation tools, or cloud integration services that can enhance their diagnostic offerings and streamline workflow management.